Novel anti-reflux biliary metal stent with a distal tapered end for distal malignant biliary obstruction: a feasibility study

Abstract

BACKGROUND & AIMS: We developed a self-expandable metallic stent (SEMS) with a distal tapered end to reproduce the physiological bile flow with a pressure gradient due to the difference in the diameter. We aimed to evaluate the safety and efficacy of the newly developed distal tapered covered metal stent (TMS) for distal malignant biliary obstruction (DMBO). METHODS: This single-center, prospective, single-arm study was conducted in patients with DMBO. The primary endpoint was time to recurrent biliary obstruction (TRBO), and the secondary endpoints were the survival time and incidence of adverse events (AEs). RESULTS: Thirty-five patients (15 men, 20 women; median age, 81 [range: 53–92] years) were enrolled between December 2017 and December 2019. The primary diseases were pancreatic head cancer in 25 cases, bile duct cancer in 8 cases, and ampullary cancer in 2 cases. TMS was successfully placed in all cases. Acute cholecystitis occurred as an early AE (within 30 days) in 2 cases (5.7%). The median TRBO was 503 days, median survival time was 239 days. RBO was observed in 10 cases (28.6%), and the causes were distal migration in 6 cases, proximal migration in 2 cases, biliary sludge in 1 case, and tumor overgrowth in 1 case. CONCLUSIONS: Endoscopic placement of the newly developed TMS in patients with DMBO is technically feasible and safe, and the TRBO was remarkably long. The anti-reflux mechanism based on the difference in diameter may be effective, and a randomized controlled trial with a conventional SEMS is required.